Dyadic (DYAI) Announces Effectiveness of Form 10 Registration Statement and Application to NASDAQ

JUPITER, FL / ACCESSWIRE / February 13, 2019 / Dyadic International, Inc. (the "Company") (OTCQX: DYAI) today announced that the Securities and Exchange Commission (the...
Biotech Stock Review

Adding Immunomedics (IMMU) $3.00 to Watch List.

Biotech Stock Review Initiates Coverage. Immunomedics (IMMU). $3.00 Epic Short Squeeze Inflection Point Nears. As posted on SeekingAlpha.

HCN: The Most Exciting Internet Powered Network We’ve Seen Launched in Decades.

Is Privately Held Hotel Communications Network Following the Footsteps of FaceBook (FB)?. (Secret: Where Facebook started on a college campus and landed one student after...
coronavirus, biotech stock review

VIDEO: Dyadic (DYAI) CEO Explains What his Industry is Doing to Defeat Coronavirus (FoxNews).

Jan. 27, 2020 - 5:24 - Dyadic International CEO Mark Emalfarb discusses what’s being done to stop the spread of coronavirus and to...
Citius Pharma

Citius Pharma (CTXR) $1.20. Price Target Upped to $4.00 at HC Wainright.

STREET INSIDER H.C. Wainwright analyst Vernon Bernardino raised the price target on Citius Pharmaceuticals (NASDAQ: CTXR) to $4.00 (from $1.65) while maintaining a Buy rating. The analyst commented,...

Two Biotech Stocks on Takeover List?

Why These 2 Biotech Stocks Might Be Next On The Takeover List (IBD). Acadia Pharmaceuticals (ACAD) and Neurocrine Biosciences (NBIX) stand out as potential takeover candidates among biotech...
biotech stock review, dyadic

Must Watch Video: Dyadic’s (DYAI) Matthew Jones.

Click here to watch the video. It's the proverbial, "everything you wanted to know" about Cho cells. "We achieved encouraging results, knowledge and experience in...

Okay, so What’s Next for Citius Pharma (CTXR) $1.16?

Dawson James Broker/Dealer Updates. Price Target Remains at $7.00. "OK, So what’s Next? Topline data from the superior efficacy interim analysis should represent the next...

Crazy Valuations at Lyft? $20 Billion for $2 Billion in Rev’s (Quartz).

Lyft warns it may never make any money. “We have a history of net losses and we may not be able to achieve or maintain...

HCN Network. Like Investing in Uber or Lyft, When They Only had 9,000 Drivers?

Internet Stock Review Report on Hotel Communications Network. HCN Communication Network has the most exciting Internet Advertising Platform we've seen since eUniverse (MySpace - past...

Latest article

Adding BCM Resources Corporation (B.V) $0.27, Up 42%, to Watch List.

'Elephant Hunter' Dr. Sergei Diakov is Expanding Drill Footprint, to Outline a Potentially Massive Copper-Gold System Beneath the Surface. Led by legendary geologist Dr. Sergei...

New Report on Sekur Private Data (SWISF). Palantir’s Open Secure AI.

Palantir CEO Alex Karp discusses open-weight artificial intelligence models, how he believes the technology should be regulated and why the U.S. should avoid Europe’s...

Replimune (REPL) Jumps 100%.

A Nifty $415 Million Gain (in an hour) for Shareholders. Not out of the woods yet.. Short and to the point: We listened to whole meeting...